Lack of access to personal protective equipment is associated with severe COVID-19 symptoms among in-person workers.

COVID-19 Personal protective equipment Severity

Journal

Preventive medicine reports
ISSN: 2211-3355
Titre abrégé: Prev Med Rep
Pays: United States
ID NLM: 101643766

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 13 06 2022
revised: 08 02 2023
accepted: 09 02 2023
entrez: 23 2 2023
pubmed: 24 2 2023
medline: 24 2 2023
Statut: ppublish

Résumé

The use of personal protective equipment (PPE) at work can greatly reduce risk of SARS-CoV-2 transmission. However, it is unclear whether adequate PPE reduces disease severity if transmission occurs. This study investigated associations between workplace access to adequate PPE and self-reported COVID-19 symptom severity among in-person workers. We used data from the Michigan COVID-19 Recovery Surveillance Study (MI CReSS), a population-based survey of Michigan adults with a PCR-confirmed positive SARS-CoV-2 test. The sample was restricted to employed, in-person respondents with COVID-19 onset on or before November 15, 2020 (n = 893). Access to adequate PPE at work was categorized as often/always, sometimes, or rarely/never. Self-reported symptom severity was dichotomized as severe (severe or very severe) or not severe (mild, moderate, or asymptomatic). We used modified Poisson regression to estimate prevalence ratios for the relationship between adequate PPE at work and severe COVID-19 symptoms. We examined effect modification of the relationship by occupation by including a multiplicative interaction term for healthcare worker versus other occupations. After adjusting for sociodemographic and clinical covariates, respondents who rarely/never had access to PPE at work had a 24.7 % higher prevalence of self-reported severe COVID-19 symptoms (PR: 1.25, 95 % CI 1.03-1.51, p-value = 0.024) compared to respondents who often/always had access to PPE at work. Healthcare worker status did not modify the association between access to PPE and symptom severity. The findings from this study suggest an added benefit of PPE in reducing prevalence of severe COVID-19 among all in-person workers.

Identifiants

pubmed: 36816766
doi: 10.1016/j.pmedr.2023.102136
pii: S2211-3355(23)00027-X
pmc: PMC9918312
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102136

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

JAMA. 2020 Nov 17;324(19):1935-1936
pubmed: 33104157
Thorax. 2021 Jan;76(1):61-63
pubmed: 32963115
Occup Environ Med. 2020 Dec 9;:
pubmed: 33298533
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
World J Crit Care Med. 2021 Jul 9;10(4):132-150
pubmed: 34316448
Am J Pathol. 2020 Sep;190(9):1881-1887
pubmed: 32628931
BMJ Glob Health. 2021 Jan;6(1):
pubmed: 33509841
Int J Infect Dis. 2020 Aug;97:290-292
pubmed: 32553720

Auteurs

Elizabeth Slocum (E)

Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.

Zoey Laskaris (Z)

Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.

Jana L Hirschtick (JL)

Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.

Patricia McKane (P)

Lifecourse Epidemiology and Genomics Division, Michigan Department of Health and Human Services, Lansing, MI, USA.

Nancy L Fleischer (NL)

Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.

Classifications MeSH